Clinical trial
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
NCT00136214 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00136214 |
|---|---|
| Title | Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects |
| Official title | A Study of the Cerebral Effect of Pegylated Interferon in Hepatitis C Positive Subjects |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis C |
| Intervention type | Diagnostic Test |
| Interventions | MR brain and neuropsychiatric tests |
| Enrollment | 22 |
| Start date | Mar 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 29, 2005 |
| Last update posted | Jul 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: